Literature DB >> 9054384

Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins.

H I Nishida1, T Nishida.   

Abstract

Phospholipid transfer protein (PLTP) purified from human plasma was found to enhance the transfer of cholesterol from single bilayer vesicles containing phosphatidylcholine and cholesterol to high density lipoprotein-3. The rate of cholesterol transfer was greatly influenced by the cholesterol content of the donor vesicles. The maximal rate was observed with the vesicles containing 20-25 mol % cholesterol. This was in contrast to a progressive decline in the rate of phosphatidylcholine transfer with an increase in the cholesterol content. To determine the binding of cholesterol and phosphatidylcholine to PLTP, the mixtures of PLTP and the vesicles containing 3H-labeled phosphatidylcholine and 14C-labeled cholesterol were incubated and subjected to sucrose density gradient centrifugation. Determination of the label profiles showed that cholesterol as well as phosphatidylcholine were transferred from the vesicles to PLTP. The reversible nature of the binding was shown by the transfer of labeled cholesterol and phosphatidylcholine bound to PLTP to the acceptor vesicles or low density lipoprotein. Isothermal equilibrium binding of PLTP for cholesterol and phosphatidylcholine showed that PLTP possessed a considerably higher affinity and binding capacity for phosphatidylcholine than for cholesterol. The phosphatidylcholine binding affinity and capacity were greater when PLTP was incubated with phosphatidylcholine vesicles without cholesterol. A possible importance of PLTP-mediated cholesterol transfer in the circulation was described.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054384     DOI: 10.1074/jbc.272.11.6959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Dry eye symptoms are increased in mice deficient in phospholipid transfer protein (PLTP).

Authors:  Niko L Setälä; Jari Metso; Matti Jauhiainen; Antti Sajantila; Juha M Holopainen
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Authors:  Calvin Yeang; Shucun Qin; Kailian Chen; David Q-H Wang; Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2010-06-11       Impact factor: 5.922

Review 3.  Tear lipocalin: structure and function.

Authors:  Darlene A Dartt
Journal:  Ocul Surf       Date:  2011-07       Impact factor: 5.033

4.  Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations.

Authors:  Nilesh Patankar; Kishor M Wasan
Journal:  Pharm Res       Date:  2006-05-10       Impact factor: 4.200

5.  Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Authors:  Marian C Cheung; Gertrud Wolfbauer; John J Albers
Journal:  Biochim Biophys Acta       Date:  2011-02-16

6.  Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.

Authors:  Simona Vuletic; Ge Li; Elaine R Peskind; Hal Kennedy; Santica M Marcovina; James B Leverenz; Eric C Petrie; Virginia M-Y Lee; Douglas Galasko; Gerard D Schellenberg; John J Albers
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 7.  Understanding and analyzing meibomian lipids--a review.

Authors:  Igor A Butovich; Thomas J Millar; Bryan M Ham
Journal:  Curr Eye Res       Date:  2008-05       Impact factor: 2.424

8.  PLTP is present in the nucleus, and its nuclear export is CRM1-dependent.

Authors:  Simona Vuletic; Weijiang Dong; Gertrud Wolfbauer; Joseph R Day; John J Albers
Journal:  Biochim Biophys Acta       Date:  2009-01-24

9.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Authors:  Marian C Cheung; Gertrud Wolfbauer; Hiroshi Deguchi; José A Fernández; John H Griffin; John J Albers
Journal:  Biochim Biophys Acta       Date:  2008-12-30

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.